Sevuparin Infusion for the Management of Acute VOC in Subjects With SCD

NCT02515838 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

147

Enrollment

INDUSTRY

Sponsor class

Conditions

Sickle-Cell Disease

Interventions

DRUG: Sevuparin
OTHER: Placebo

Sponsor

Modus Therapeutics AB

Collaborators

[object Object]